American Pharmaceutical Partners and Glaxo Wellcome Announce Manufacturing and Supply Agreement for Acyclovir IV.SANTA MONICA, Calif.--(BW HealthWire)--July 8, 1997--American Pharmaceutical Partners and Glaxo Wellcome Inc. announced an agreement whereby Glaxo Wellcome will manufacture and supply American Pharmaceutical Partners with 500 mg and 1000 mg formulations of lyophilized ly·oph·i·lize tr.v. ly·oph·i·lized, ly·oph·i·liz·ing, ly·oph·i·liz·es To freeze-dry (blood plasma or other biological substances). [lyophil(ic) + -ize. acyclovir acyclovir /acy·clo·vir/ (a-si´klo-ver) a synthetic purine nucleoside with selective activity against herpes simplex virus; used as the base or the sodium salt in the treatment of genital and mucocutaneous herpesvirus infections. . Acyclovir is the generic equivalent of the leading anti-viral drug, Zovirax. Acyclovir is indicated for the treatment of genital herpes Genital Herpes Definition Genital herpes is a sexually transmitted disease caused by a herpes virus. The disease is characterized by the formation of fluid-filled, painful blisters in the genital area. , herpes zoster herpes zoster, infection of a ganglion (nerve center) with severe pain and a blisterlike eruption in the area of the nerve distribution, a condition called shingles. (shingles shingles: see herpes zoster. shingles or herpes zoster Acute viral skin and nerve infection. Groups of small blisters appear along certain nerve segments, most often on the back, sometimes after a dull ache at the site; pain becomes ) and chicken pox chicken pox or varicella (vâr'əsĕl`ə), infectious disease usually occurring in childhood. It is believed to be caused by the same herpesvirus that produces shingles. . Glaxo Wellcome's Zovirax had total U.S. sales of $488 million in 1996. American Pharmaceutical Partners is currently awaiting approval of a ready-to-use I.V. formulation of acyclovir. American Pharmaceutical Partners (APP), with headquarters in Santa Monica, is a subsidiary of VivoRx Pharmaceuticals Inc. (VPI VPI Voice Print International (Camarillo, CA) VPI Virtual Path Identifier (used in Asynchronous Transfer Mode) VPI Virginia Polytechnic Institute (aka Virginia Tech) ), a member of the VivoRx group of companies. VPI is a development- stage biopharmaceutical company committed to the development and commercialization of therapeutics utilizing proprietary next generation delivery systems. This agreement with Glaxo Wellcome, the world's largest pharmaceutical company, initiates APP's strategy to enter into collaborative agreements with major ethical pharmaceutical companies to market and distribute major proprietary drugs prior to or upon patent expiration. The significant technical drug and gene-delivery proprietary platform of VPI provides an opportunity for line extensions of such products and the development of next generation proprietary therapeutics. APP believes that the unique relationships it enjoys with large group purchasing organizations positions the company to gain significant market share of selected generic products. Glaxo Wellcome is a research-based company committed to fighting disease by bringing innovative medicines and services to patients and the health care providers who serve them. Glaxo Wellcome Inc., a subsidiary of Glaxo Wellcome plc., is the nation's leading research-based pharmaceutical firm and has headquarters in Research Triangle Park Research Triangle Park, research, business, medical, and educational complex situated in central North Carolina. It has an area of 6,900 acres (2,795 hectares) and is 8 × 2 mi (13 × 3 km) in size. Named for the triangle formed by Duke Univ. , N.C. American Pharmaceutical Partners is committed to being the leading company in the development, manufacture and marketing of proprietary and high-value injectable pharmaceutical products. APP has established contractual supply agreements with high-volume pharmaceutical purchasing organizations, including Premier, the country's largest group purchasing organization. CONTACT: American Pharmaceutical Partners, Santa Monica Jeffrey Yordon, 310/264-7768 or VivoRx Pharmaceuticals Inc., Santa Monica Patrick Soon-Shiong, 310/264-7768 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion